{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:40:54Z","timestamp":1789656054680,"version":"4.0.1"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2026,1,20]]},"abstract":"<jats:p>This JAMA Insights discusses the clinical presentation, diagnosis, and treatment of primary biliary cholangitis.<\/jats:p>","DOI":"10.1001\/jama.2025.20067","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T16:30:54Z","timestamp":1762792254000},"page":"269","source":"Crossref","is-referenced-by-count":8,"title":["Primary Biliary Cholangitis"],"prefix":"10.1001","volume":"335","author":[{"given":"Michele M.","family":"Tana","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon M.","family":"Hirschfield","sequence":"additional","affiliation":[{"name":"The Autoimmune and Rare Liver Disease Programme, Division of Gastroenterology and Hepatology, Toronto General Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9","key":"jit250041r1","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S2468-1253(25)00025-1","article-title":"Primary biliary cholangitis and the narrowing gap towards optimal disease control.","volume":"10","author":"Can\u00e7ado","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"jit250041r2","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","article-title":"Recent advances in clinical practice.","volume":"70","author":"Trivedi","year":"2021","journal-title":"Gut"},{"issue":"4","key":"jit250041r3","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/hep.32117","article-title":"Primary biliary cholangitis.","volume":"75","author":"Lindor","year":"2022","journal-title":"Hepatology"},{"issue":"2","key":"jit250041r4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1053\/cgh.2003.50014","article-title":"When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?","volume":"1","author":"Zein","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"jit250041r5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.14309\/ajg.0000000000003029","article-title":"COBALT: a confirmatory trial of obeticholic acid in primary biliary cholangitis with placebo and external controls.","volume":"120","author":"Kowdley","year":"2025","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"jit250041r6","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa2306185","article-title":"Efficacy and safety of elafibranor in primary biliary cholangitis.","volume":"390","author":"Kowdley","year":"2024","journal-title":"N Engl J Med"},{"issue":"9","key":"jit250041r7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/NEJMoa2312100","article-title":"A phase 3 trial of seladelpar in primary biliary cholangitis.","volume":"390","author":"Hirschfield","year":"2024","journal-title":"N Engl J Med"},{"issue":"7","key":"jit250041r8","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.14309\/ajg.0000000000000557","article-title":"Goals of treatment for improved survival in primary biliary cholangitis.","volume":"115","author":"Murillo Perez","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"jit250041r9","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jhep.2022.06.017","article-title":"Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis.","volume":"77","author":"Corpechot","year":"2022","journal-title":"J Hepatol"},{"issue":"8","key":"jit250041r10","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.cgh.2023.02.005","article-title":"New treatment paradigms in primary biliary cholangitis.","volume":"21","author":"Levy","year":"2023","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2841074\/jama_tana_2025_it_250041_1767896111.04682.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:00:50Z","timestamp":1768924850000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2841074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,1,20]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2025.20067","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,20]]}}}